What is he best known for?
The fields of study he is best known for:
His primary areas of study are Polycystic kidney disease, Endocrinology, Internal medicine, Autosomal dominant polycystic kidney disease and PKD1.
His study in Polycystic kidney disease is interdisciplinary in nature, drawing from both Cilium, Cell biology and Pathogenesis.
His Endocrinology research includes elements of Cyst, Cancer research and Bioinformatics.
His research investigates the link between Cyst and topics such as Kidney disease that cross with problems in Pathology.
His Autosomal dominant polycystic kidney disease research is multidisciplinary, relying on both Metformin, Signal transduction and Protein kinase A.
PKD1 is the subject of his research, which falls under Genetics.
His most cited work include:
- PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein (1150 citations)
- Two Populations of Node Monocilia Initiate Left-Right Asymmetry in the Mouse (668 citations)
- Polycystin-2 is an intracellular calcium release channel (569 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Polycystic kidney disease, Autosomal dominant polycystic kidney disease, PKD1, Genetics and Internal medicine.
His Polycystic kidney disease study combines topics in areas such as Cyst, Kidney cysts and Cilium.
Stefan Somlo is interested in Polycystin 2, which is a branch of Autosomal dominant polycystic kidney disease.
His PKD1 research includes themes of Frameshift mutation, Allele, Cell growth and Cell biology.
Stefan Somlo combines topics linked to Endocrinology with his work on Internal medicine.
The study incorporates disciplines such as Triptolide and Calcium, Calcium signaling in addition to Endocrinology.
He most often published in these fields:
- Polycystic kidney disease (47.00%)
- Autosomal dominant polycystic kidney disease (43.50%)
- PKD1 (35.50%)
What were the highlights of his more recent work (between 2013-2021)?
- Polycystic kidney disease (47.00%)
- Autosomal dominant polycystic kidney disease (43.50%)
- PKD1 (35.50%)
In recent papers he was focusing on the following fields of study:
Stefan Somlo mainly focuses on Polycystic kidney disease, Autosomal dominant polycystic kidney disease, PKD1, Cilium and Internal medicine.
He interconnects Cyst, Cancer research and Renal function in the investigation of issues within Polycystic kidney disease.
His Autosomal dominant polycystic kidney disease study is concerned with Genetics in general.
His PKD1 research is multidisciplinary, incorporating elements of Kidney cysts, PI3K/AKT/mTOR pathway and Gene.
His research in Cilium intersects with topics in Polycystin 2 and Pathogenesis.
His Internal medicine research is multidisciplinary, relying on both Endocrinology, Gene knockdown and RNA interference.
Between 2013 and 2021, his most popular works were:
- Altered trafficking and stability of polycystins underlie polycystic kidney disease (89 citations)
- Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease (85 citations)
- Polycystin-1: a master regulator of intersecting cystic pathways. (74 citations)
In his most recent research, the most cited papers focused on:
Polycystic kidney disease, Autosomal dominant polycystic kidney disease, Cilium, PKD1 and Cell biology are his primary areas of study.
His Polycystic kidney disease study integrates concerns from other disciplines, such as Cyst, Cancer research and Gerontology.
Genetics covers Stefan Somlo research in Autosomal dominant polycystic kidney disease.
A large part of his PKD1 studies is devoted to Polycystin-1.
His studies in Cell biology integrate themes in fields like Polycystin complex, Polycystin 2, Internal medicine and Endocrinology.
His study in Polycystin 2 is interdisciplinary in nature, drawing from both Cystic kidney disease and Signal transduction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
